Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR T‐cell therapy of solid tumors
Carmen S. Yong, Valérie Dardalhon, Christel Devaud, et al.
Immunology and Cell Biology (2016) Vol. 95, Iss. 4, pp. 356-363
Open Access | Times Cited: 202

Showing 1-25 of 202 citing articles:

From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)
Volker Schirrmacher
International Journal of Oncology (2018) Vol. 54, Iss. 2, pp. 407-419
Open Access | Times Cited: 1090
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
Rigel J. Kishton, Madhusudhanan Sukumar, Nicholas P. Restifo
Cell Metabolism (2017) Vol. 26, Iss. 1, pp. 94-109
Open Access | Times Cited: 468
Clinical update on head and neck cancer: molecular biology and ongoing challenges
Elham Alsahafi, Katheryn Begg, Ivano Amelio, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 8
Open Access | Times Cited: 438
Immunotherapy and Prevention of Pancreatic Cancer
Alexander H. Morrison, Katelyn T. Byrne, Robert H. Vonderheide
Trends in cancer (2018) Vol. 4, Iss. 6, pp. 418-428
Open Access | Times Cited: 377
Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity
Alexander J. Davenport, Ryan S. Cross, Katherine A. Watson, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 9
Open Access | Times Cited: 289
T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses
Alireza Saeidi, Keivan Zandi, Yi Ying Cheok, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 283
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
Siwei Wang, Chao Gao, Yi-Min Zheng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 259
Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care
Christopher M. Hartshorn, Michelle S. Bradbury, Gregory M. Lanza, et al.
ACS Nano (2017) Vol. 12, Iss. 1, pp. 24-43
Open Access | Times Cited: 231
Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases
Asghar Fallah, Ali Sadeghinia, Houman Kahroba, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 110, pp. 775-785
Open Access | Times Cited: 214
Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance
Megha Budhwani, Roberta Mazzieri, Riccardo Dolcetti
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 171
CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
Hannah M. Knochelmann, Aubrey S. Smith, Connor J. Dwyer, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 170
Metabolic Barriers to T Cell Function in Tumors
Ayaka Sugiura, Jeffrey C. Rathmell
The Journal of Immunology (2018) Vol. 200, Iss. 2, pp. 400-407
Open Access | Times Cited: 168
Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment
Li Yang, Aitian Li, Qingyang Lei, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 164
Cellular networks controlling T cell persistence in adoptive cell therapy
Jack D. Chan, Junyun Lai, Clare Y. Slaney, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 12, pp. 769-784
Closed Access | Times Cited: 159
Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
Babak Moghimi, Sakunthala Muthugounder, Samy Jambon, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 121
Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies
Hongjian Li, Kun Peng, Kai Yang, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6422-6436
Open Access | Times Cited: 118
Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects
Zhuoyan Liu, Xuan Liu, Jiaxin Liang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 113
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Zaoqu Liu, Zhaokai Zhou, Qin Dang, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6273-6290
Open Access | Times Cited: 85
CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application
Yu-Huan Yang, Jiawei Liu, Lü Chen, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 6, pp. 2609-2626
Open Access | Times Cited: 81
Immunotherapy for hepatocellular carcinoma: Current status and future perspectives
Deepa S. Mandlik, Satish K. Mandlik, Heena B Choudhary
World Journal of Gastroenterology (2023) Vol. 29, Iss. 6, pp. 1054-1075
Open Access | Times Cited: 61
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Kaveh Hadiloo, Safa Tahmasebi, Abdolreza Esmaeilzadeh
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 48
GLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy
Yuzhe Shi, Ivan S Kotchetkov, Anton Dobrin, et al.
Molecular Therapy (2024) Vol. 32, Iss. 7, pp. 2393-2405
Open Access | Times Cited: 16
Neuroblastoma Origin and Therapeutic Targets for Immunotherapy
И. В. Холоденко, Daniel Kalinovsky, Igor I. Doronin, et al.
Journal of Immunology Research (2018) Vol. 2018, pp. 1-25
Open Access | Times Cited: 153
Anti-GD2 immunotherapy for neuroblastoma
Sameer Farouk Sait, Shakeel Modak
Expert Review of Anticancer Therapy (2017) Vol. 17, Iss. 10, pp. 889-904
Open Access | Times Cited: 152
Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors
Meijia Yang, Xin Tang, Zongliang Zhang, et al.
Theranostics (2020) Vol. 10, Iss. 17, pp. 7622-7634
Open Access | Times Cited: 129
Page 1 - Next Page

Scroll to top